The best treatment for secondary hyperparathyroidism is surgery.
Beverly Hills, CA (PRWEB) December 11, 2013
A recent study set to be published in the Journal of Clinical Endocrinology & Metabolism by The Endocrine Society revealed a new way to test for parathyroid hormone imbalances in patients with end-stage kidney disease. At the CENTER for Advanced Parathyroid Surgery, hyperparathyroidism specialist Dr. Babak Larian understands how crucial it is for kidney disease patients to receive an accurate diagnosis.
“Secondary hyperparathyroidism is actually quite common among those suffering from chronic kidney failure. Left undetected, parathyroid gland imbalances can be fatal to these patients,” explained Dr. Larian.
Parathyroid hormone often becomes oxidized in patients with end-stage kidney disease, which causes the hormone to be biologically inactive. Traditional tests for parathyroid hormone levels are ineffective because oxidized parathyroid hormone may not adequately reflect these inactive hormones although they are present in the body. The new testing method is an innovative technique that will differentiate between biologically active (non-oxidized) and biologically inactive (oxidized) parathyroid hormone.
“The ability to improve the detection of oxidized parathyroid hormone would be a great improvement in diagnosing and treating kidney disease patients with secondary hyperparathyroidism,” said Dr. Larian.
Hyperparathyroidism is a condition caused by an overproduction of parathyroid hormone from an abnormal parathyroid gland, which is responsible for maintaining balanced levels of calcium in the body. Those with secondary hyperparathyroidism have a low level of Vitamin D oftentimes caused by kidney disease. A low Vitamin D level will have an effect on the amount of calcium in the body which can stimulate production of the parathyroid hormone. At the CENTER for Advanced Parathyroid Surgery in Beverly Hills, board-certified surgeon Dr. Larian is a pioneer in treating parathyroid disease performing the innovative minimally invasive parathyroidectomy.
“The best treatment for secondary hyperparathyroidism is surgery. Patients should seek a parathyroid expert who is knowledgeable about treating this condition in the safest and most minimally invasive way,” stated Dr. Larian.
Dr. Babak Larian, the Director of the CENTER for Advanced Parathyroid Surgery in Los Angeles, is a highly experienced and reputable board-certified head and neck surgeon. Dr. Larian is nationally renowned for his expertise in minimally invasive surgery techniques involving parathyroid disorders and is considered a pioneer in his field. Currently, Dr. Larian holds the prestigious honor of Chief of Head & Neck Surgery at Cedars-Sinai Medical Center and Assistant Clinical Professor of Surgery at UCLA.
For additional information regarding Dr. Larian and the various services offered at the CENTER for Advanced Parathyroid surgery, please visit http://www.parathyroidmd.com or call 310-461-0300.